Esophageal Cancer, Pancreatic Cancer, Stomach Cancer
Conditions
Brief summary
Follow-up after successful operative treatment of cancer in the esophagus, stomach or pancreas in order to detect recurrent disease is a controversial topic. This is because the methods and the consequence of following these patients is unknown. Therefore the investigators will randomize these patients in to two groups: 1. One group of patients will be offered visits with a specialist surgeon in a outpatient setting for a clinical evaluation every 3,6,9,12,18 and 24 months after surgery, as is the current standard at our department. 2. The other group will be offered Endoscopic UltraSound, EUS, and PET/CT with the same intervals as the first group.
Interventions
BEHAVIORALstandard follow-up
Outpatient clinic visits
PROCEDUREPET/CT and EUS
PET/CT and EUS
Sponsors
Odense University Hospital
Michael Bau Mortensen
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* R0- resection for primary adenocarcinoma or squamous cell carcinoma of the esophagus, stomach or pancreas.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients eligible for treatment | 2 years | Does early detection of recurrent disease translate in to more patients being eligible for oncologic treatment? |
Countries
Denmark
Outcome results
None listed